Biochem Pharmaceutical Industries Limited Part Ix - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2004.
2004 Ahmedabad, Gujarat, India Amalgamated
Last Updated:
Access Report
About Biochem Pharmaceutical Industries Limited Part Ix

Biochem Pharmaceutical Industries Limited Part Ix, a amalgamated public limited company, was established on 04 November 2004 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2004PLC094323. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹7.50 Cr.

Its leadership includes Bhavana Sharadchandra Doshi (Director), Ganesh Narayan Nayak (Director), Anilkumar Matai (Director). Past directors included Bhavana Sharadchandra Doshi, Sudhakar Govinda Chaudhari, Ganesh Narayan Nayak. It holds ₹40.00 Cr open charges and ₹13.85 Cr settled loans. Its latest AGM occurred on 04 August 2016, with the balance sheet filed on 31 March 2016. It is based at Zydustower,Satellitecrossroad,Sarkhej-Gandhinagarhighway,, Ahmedabad, Gujarat, 380015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2004PLC094323

  • Registration Number

    094323

  • Incorporation Date

    04 November 2004

  • Authorized Capital

    ₹12.00 Cr

  • Paid-Up Capital

    ₹7.50 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 7.50 Cr
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 31 Mar 2016
  • Open Charges ₹ 40.00 Cr
  • Satisfied Charges ₹ 13.85 Cr
Company report

Biochem Pharmaceutical Industries Limited Part Ix

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biochem Pharmaceutical Industries Limited Part Ix — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Biochem Pharmaceutical Industries Limited Part Ix?
Current Directors
Name Designation Appointment Date Status
Bhavana Sharadchandra Doshi Director 13 Jan 2015 Current
Ganesh Narayan Nayak Director 21 Dec 2011 Current
Anilkumar Matai Director 10 Nov 2014 Current
Deevyesh Jagjivan Radia Director 13 Jan 2015 Current
Mayank Jashwantlal Shah Director 04 Nov 2004 Current
Nitinkumar Dalsukhray Parekh Director 21 Dec 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 05 Aug 2015 Past
Pramod Abcsdd Additional Director 01 May 2010 Past
Pramod Abcsdd Additional Director 26 Jul 2012 Past
Pramod Abcsdd Additional Director 29 Sep 2008 Past
Pramod Abcsdd Whole-Time Director 23 Jan 2015 Past
Pramod Abcsdd Additional Director 05 Aug 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biochem Pharmaceutical IndustriesPart Ix.

Enhance accessibility to Biochem Pharmaceutical IndustriesPart Ix's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Biochem Pharmaceutical IndustriesPart Ix revenue growth over time
Biochem Pharmaceutical IndustriesPart Ix profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biochem Pharmaceutical IndustriesPart Ix?

In 2016, Biochem Pharmaceutical IndustriesPart Ix had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹400,000,000.00

Satisfied Charges

₹138,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 40.00 Cr
Latest Charge Details
Date Lender Amount Status
08 Aug 2012 Hdfc Bank Limited ₹40.00 Cr Open
27 Apr 2006 Union Bank Of India Limited ₹5.25 Cr Satisfied
10 Jan 2006 Union Bank Of India ₹0.50 M Satisfied
10 Jan 2006 Union Bank Of India ₹0.50 M Satisfied
07 Jan 2006 Union Bank Of India ₹1.75 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biochem Pharmaceutical IndustriesPart Ix?

Unlock and access historical data on people associated with Biochem Pharmaceutical IndustriesPart Ix, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biochem Pharmaceutical IndustriesPart Ix, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biochem Pharmaceutical IndustriesPart Ix's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biochem Pharmaceutical IndustriesPart Ix
Recent Activity within the Organization
  • Annual General Meeting

    The activity Biochem Pharmaceutical Industries Limited Part Ix last Annual general meeting of members was held on 04 Aug 2016 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Biochem Pharmaceutical Industries Limited Part Ix has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Ahmedabad. was completed.

  • Director Appointment

    The activity Bhavana Sharadchandra Doshi was appointed as a Director was appointed as a Director on 13 Jan 2015 & has been associated with this company since 11 years 1 month . was completed.

  • Director Appointment

    Deevyesh Jagjivan Radia was appointed as a Director was appointed as a Director on 13 Jan 2015 & has been associated with this company since 11 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Anilkumar Matai was appointed as a Director was appointed as a Director on 10 Nov 2014 & has been associated with this company since 11 years 3 months . was completed.

  • Charges

    The activity A charge registered on 27 Apr 2006 via Charge ID 10007694 with Union Bank Of India Limited was fully satisfied on 14 Sep 2012. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biochem Pharmaceutical Industries Limited Part Ix?

The CIN of Biochem Pharmaceutical Industries Limited Part Ix is U24230GJ2004PLC094323.

Where is Biochem Pharmaceutical Industries Limited Part Ix headquartered?

Biochem Pharmaceutical Industries Limited Part Ix is headquartered at Zydustower,Satellitecrossroad,Sarkhej-Gandhinagarhighway,, Ahmedabad, Gujarat, 380015.

When was Biochem Pharmaceutical Industries Limited Part Ix incorporated?

Biochem Pharmaceutical Industries Limited Part Ix was incorporated on 04 November 2004.

Who are the current directors of Biochem Pharmaceutical Industries Limited Part Ix?

The current directors of Biochem Pharmaceutical Industries Limited Part Ix are

What is the primary industry of Biochem Pharmaceutical Industries Limited Part Ix?

The primary industry of Biochem Pharmaceutical Industries Limited Part Ix is Manufacturing.

Is Biochem Pharmaceutical Industries Limited Part Ix a listed company?

Biochem Pharmaceutical Industries Limited Part Ix is unlisted.

What is the capital structure of Biochem Pharmaceutical Industries Limited Part Ix?

The authorized capital of Biochem Pharmaceutical Industries Limited Part Ix is ₹12.00 Cr, and the paid-up capital is ₹7.50 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available